Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2011
06/30/2011US20110160129 Therapeutic Agent Preparations for Delivery Into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device
06/30/2011US20110160128 Corin for Treating Obesity and Diabetes
06/30/2011US20110159128 Alcohol metabolism enhancer and alcoholic beverage
06/30/2011US20110159127 Extract of toona sinensis from supercritical fluid extraction for treating diabetes and metabolic diseases, the preparation method and the use thereof
06/30/2011US20110159118 Screening Method (Metabolite Grid) for Therapeutic Extracts and Molecules for Diabetes
06/30/2011US20110159112 Recombinant alpha-fetoprotein and compositions thereof
06/30/2011US20110159104 Microemulsion
06/30/2011US20110159088 ORAL PHARMACEUTICAL FOR BASED ON AT LEAST ONE ACTIVE PRINCIPLE WHOSE SOLUBILITY VARIES AS A FUNCTION OF THE GASTRIC pH CONDITIONS
06/30/2011US20110159087 Crosslinked Polymers
06/30/2011US20110159086 Pharmaceutical formulation comprising a cb1-receptor compound in a solid solution and/or solid dispersion
06/30/2011US20110159083 Nanoparticles for protein drug delivery
06/30/2011US20110159082 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
06/30/2011US20110159055 Nutritional supplement for use under physiologically stressful conditions
06/30/2011US20110159045 Method of treating dysglycemia and glucose excursions
06/30/2011US20110159010 Compositions and Methods for Decreasing Type III Deiodinase Activity to Modulate Adiposity and Blood Glucose Levels
06/30/2011US20110158992 Engineered Anti-IL-23R Antibodies
06/30/2011US20110158980 Methods to treat and screen for agents to treat obesity
06/30/2011US20110158979 Genetic component of complications in type 2 diabetes
06/30/2011US20110158976 Enzymes for pharmaceutical use
06/30/2011US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
06/30/2011US20110158968 Methods of making enhanced, autologous fat grafts
06/30/2011US20110158962 Dental pulp marrow similar cells (dpmsc) and methods of isolating and using
06/30/2011US20110158961 Materials and methods relating to cell based therapies
06/30/2011US20110158935 Substituted Diketopiperazine Analogs for Use as Drug Delivery Agents
06/30/2011US20110158932 Methods And Compositions For The Treatment of Hyperlipidemia
06/30/2011US20110158910 Microparticles comprising polymers with thioester bonds
06/30/2011DE102006053637B4 Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New fluoro-substituted 1,4-benzothiepine-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use
06/30/2011DE102006053635B4 Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New substituted benzyl 1,4-benzothiepine-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use
06/30/2011CA2785674A1 Novel 3-hydroxy-5-arylisothiazole derivative
06/30/2011CA2785268A1 Composition containing bacterium capable of producing propionic acid bacterium, and use thereof
06/30/2011CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor
06/30/2011CA2784179A1 Emulsion composition
06/29/2011EP2339351A1 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide
06/29/2011EP2339035A1 Endogenous retroviruses up-regulated in prostate cancer
06/29/2011EP2338976A1 Lactic acid bacterium having high oxalic acid decomposition ability
06/29/2011EP2338908A1 Peptides containing post-translational modifications and their use in the treatment of autoimmune pathologies
06/29/2011EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
06/29/2011EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using
06/29/2011EP2338497A1 Treatment and prevention of heat shock protein-associated diseases and conditions
06/29/2011EP2338484A1 Metabolic imprinting effects of structured lipids
06/29/2011EP2337569A2 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
06/29/2011EP2337564A1 A method for combating adverse effects arising from antipsychotic treatment
06/29/2011EP2114937B1 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals
06/29/2011EP1849774B1 CYCLOHEPTA(b)PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME
06/29/2011EP1414314B1 Composition for lowering blood cholesterol
06/29/2011EP1322315B1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid
06/29/2011EP1233943B1 Ionizable indolinone derivatives and their use as ptk ligands
06/29/2011CN201880198U Treating bag of peripheral nerves of diabetes mellitus
06/29/2011CN1972932B Compounds for treating dyslipidemia
06/29/2011CN1850112B Polyethylene glycol electrolyte oral solution
06/29/2011CN1427889B Hybrid cells obtainable from antigen presenting cells
06/29/2011CN102112495A Dual variable domain immunoglobulins and uses thereof
06/29/2011CN102112494A Dual variable domain immunoglobulins and uses thereof
06/29/2011CN102112483A Solid forms of (2s, 3r, 4r, 5s, 6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3, 4, 5-triol and methods of their use
06/29/2011CN102112475A Imidazopyridine and related analogs as sirtuin modulators
06/29/2011CN102112465A Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
06/29/2011CN102112134A Composition for prevention or treatment of hyperlipidemia, fatty liver or obesity
06/29/2011CN102112127A Escalating dosing regimen for effecting weight loss and treating obesity
06/29/2011CN102112126A Low dose topiramate/phentermine compostion and methods of use thereof
06/29/2011CN102112122A Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof
06/29/2011CN102108372A Preparation method and application of beta-glucan
06/29/2011CN102108097A Novel GLP-1 (glucagon-like peptide-1) derivative
06/29/2011CN102107006A Coupling medicament for treating diabetes mellitus and medicinal application thereof
06/29/2011CN102106957A Chinese medicinal composition for treating hyperlipidemia
06/29/2011CN102106939A Quality control method for extract concentrated liquor of condensed pills of six ingredients with rehmannia root
06/29/2011CN102106932A Medicament for treating diabetic foot
06/29/2011CN102106927A Fat-clearing pressure-reducing tea
06/29/2011CN102106922A Chinese medicine for treating diabetes mellitus
06/29/2011CN102106898A Composition for treating impaired glucose tolerance and preparation method thereof
06/29/2011CN102106897A Active ammonia peptide nutrient and preparation method thereof
06/29/2011CN102106895A Composition with function of regulating blood fat
06/29/2011CN102106884A Medicinal composition having immunity-regulating function
06/29/2011CN102106875A Method for extracting water-soluble alpha-glucosidase inhibitor
06/29/2011CN102106871A Compound calcium supplement injection for pets
06/29/2011CN102106870A Method for preparing high-density calcium carbonate granules
06/29/2011CN102106840A Gemfibrozil capsule and preparation method thereof
06/29/2011CN102106837A Glipizide sustained release tablets and preparation method thereof
06/29/2011CN102106835A Method for preparing simvastatin tablet by employing micronizing and power direct compressing technologies
06/29/2011CN102106834A Pioglitazone hydrochloride chewable tablets and preparation method thereof
06/29/2011CN102106823A Resveratrol composite fine particle preparation process applying supercritical fluid crystallization technology
06/29/2011CN102106818A Isoliquiritigenin micro-emulsion composition
06/29/2011CN102106816A Resveratrol nanometer preparation and preparation method thereof
06/29/2011CN102106587A Preparation method and application of extracts from natural plants
06/29/2011CN102106417A Dandelion health-preservation tea
06/29/2011CN101904862B Water-soluble vitamin composition freeze-drying preparation for injection
06/29/2011CN101869692B Curcumin self-microemulsion and preparation method thereof
06/29/2011CN101843831B Chinese medicament for treating diabetic cardiopathy
06/29/2011CN101791352B Phenformin-containing traditional Chinese and western medicine composition
06/29/2011CN101791350B Glibenclamide-containing traditional Chinese and western medicine composition
06/29/2011CN101708237B Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof
06/29/2011CN101607051B Traditional Chinese medicine composition for losing weight and preparation method thereof
06/29/2011CN101591374B Steroid compound, preparation method thereof, medicinal composition containing compound and application of compounds
06/29/2011CN101580525B Method for extracting salidroside, polysaccharose and tannin-type substances from rhodiola root crude drugs
06/29/2011CN101549045B Traditional Chinese medicine preparation for treating diabetes and preparation method thereof
06/29/2011CN101548757B Insoluble dietary fiber of raisin tree and preparing method thereof
06/29/2011CN101507738B Preparation method of Shu Xuening injection
06/29/2011CN101491532B Erigeron breviscapus eye-preparation and preparation method thereof
06/29/2011CN101485865B Chinese medicine fat-reducing plaster
06/29/2011CN101301314B Technique for producing liver extract
06/29/2011CN101233231B Anti-obesity agent and anti-obesity food